These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17889059)

  • 1. Cardiovascular risk markers in adolescent girls with anorexia nervosa.
    Arisaka O; Ichikawa G; Yamazaki Y; Shimura N
    J Pediatr; 2007 Oct; 151(4):e16; author reply e16. PubMed ID: 17889059
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study.
    Onat A; Can G; Ciçek G; Ayhan E; Doğan Y
    Clin Biochem; 2010 Dec; 43(18):1381-6. PubMed ID: 20816677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome.
    Clarenbach JJ; Grundy SM; Palacio N; Vega GL
    J Investig Med; 2007 Jul; 55(5):237-47. PubMed ID: 17850735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk.
    Carnevale Schianca GP; Pedrazzoli R; Onolfo S; Colli E; Cornetti E; Bergamasco L; Fra GP; Bartoli E
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):406-11. PubMed ID: 20171854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL cholesterol. New measurements of risk.
    Mayo Clin Health Lett; 2011 May; 29(5):1-3. PubMed ID: 21656931
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa.
    Misra M; Miller KK; Tsai P; Stewart V; End A; Freed N; Herzog DB; Goldstein M; Riggs S; Klibanski A
    J Pediatr; 2006 Dec; 149(6):763-769. PubMed ID: 17137889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.
    Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughazala E; Bouslama A
    Metab Syndr Relat Disord; 2010 Dec; 8(6):515-22. PubMed ID: 20715933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of assessment techniques: plasma lipid and lipoproteins related to the metabolic syndrome.
    Davy BM; Davy KP
    Lipids Health Dis; 2006 Jan; 5():3. PubMed ID: 16448573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids and apolipoprotein B values, blood pressure and pulse rate in anorexia nervosa.
    Sánchez-Muniz FJ; Marcos A; Varela P
    Eur J Clin Nutr; 1991 Jan; 45(1):33-6. PubMed ID: 1855497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
    Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Lukes J; Halenka M; Frohlich J
    Clin Biochem; 2009 Aug; 42(12):1246-51. PubMed ID: 19450572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are LDL subclass measurements clinically relevant?
    Stein EA
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):120-1. PubMed ID: 16932267
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia.
    Weinbrenner T; Züger M; Jacoby GE; Herpertz S; Liedtke R; Sudhop T; Gouni-Berthold I; Axelson M; Berthold HK
    Br J Nutr; 2004 Jun; 91(6):959-69. PubMed ID: 15182399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Circulation; 1997 Jan; 95(1):1-4. PubMed ID: 8994405
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.
    Olson EJ; Pearce GL; Jones NP; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2289-94. PubMed ID: 22814748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample.
    Franco L; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G
    Metabolism; 2013 Aug; 62(8):1081-7. PubMed ID: 23477808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis].
    Frey J; Couderc R
    Ann Biol Clin (Paris); 1998; 56(5):517-20. PubMed ID: 9769517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.